Eslam B. Elkaeed

6.5k citations

254 papers · 5.3k indexed · 1 hit paper · h-index 38

Organic Chemistry top 0.5%
Molecular Biology top 5%
Computational Theory and Mathematics top 0.5%
Oncology top 5%
Toxicology top 0.1%

Co-authors: Ibrahim H. Eissa Ahmed M. Metwaly Hazem Elkady Wagdy M. Eldehna Aisha A. Alsfouk Ibrahim M. Ibrahim Ahmed A. Al‐Karmalawy Bshra A. Alsfouk
Topics: Synthesis and biological activity (80 papers)Computational Drug Discovery Methods (44 papers)Bioactive Compounds and Antitumor Agents (31 papers)
Cited by: Toxicology Organic Chemistry Computational Theory and Mathematics
Journals: SHILAP Revista de lepidopterologíaPLoS ONE International Journal of Molecular Sciences
Partner nations: Saudi Arabia Egypt Pakistan

In The Last Decade

Eslam B. Elkaeed

243 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor

2021 209 citations Mohammed A. Dahab, Ahmed M. Metwaly et al. Frontiers in Chemistry profile →

Peers

Countries citing papers authored by Eslam B. Elkaeed

Since Specialization

Citations

This map shows the geographic impact of Eslam B. Elkaeed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eslam B. Elkaeed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eslam B. Elkaeed more than expected).

Fields of papers citing papers by Eslam B. Elkaeed

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eslam B. Elkaeed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eslam B. Elkaeed. The network helps show where Eslam B. Elkaeed may publish in the future.

Co-authorship network of co-authors of Eslam B. Elkaeed

This figure shows the co-authorship network connecting the top 25 collaborators of Eslam B. Elkaeed. A scholar is included among the top collaborators of Eslam B. Elkaeed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eslam B. Elkaeed. Eslam B. Elkaeed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	New nicotinamide–thiadiazol hybrids as VEGFR-2 inhibitors for breast cancer therapy: design, synthesis and in silico and in vitro evaluation 2025 ·RSC Advances ·Walid E. Elgammal,Hazem Elkady,Reda G. Yousef,Wagdy M. Eldehna,Dalal Z. Husein,(unknown),Bshra A. Alsfouk,Eslam B. Elkaeed,Ibrahim H. Eissa,Ahmed M. Metwaly	4
2	Development of new thieno[2,3-d]pyrimidines as dual EGFR and STAT3 inhibitors endowed with anticancer and pro-apoptotic activities 2024 ·Bioorganic Chemistry ·(unknown),Tarek F. El‐Moselhy,Eman A. El-Bastawissy,(unknown),Rehab Mustafa Badi,Eslam B. Elkaeed,Moataz A. Shaldam,Wagdy M. Eldehna,Haytham O. Tawfik	21
3	New thiazolidine-2,4-diones as potential anticancer agents and apoptotic inducers targeting VEGFR-2 kinase: Design, synthesis, in silico and in vitro studies 2024 ·Biochimica et Biophysica Acta (BBA) - General Subjects ·Hazem Elkady,Hazem A. Mahdy,Mohammed S. Taghour,Mohammed A. Dahab,Alaa Elwan,Mohamed Hagras,(unknown),Ibrahim M. Ibrahim,Dalal Z. Husein,Eslam B. Elkaeed,Aisha A. Alsfouk,Ahmed M. Metwaly,Ibrahim H. Eissa	13
4	Integrated in silico and in vitro discovery of a new anticancer thiadiazole analog targeting VEGFR-2 2024 ·Journal of Molecular Structure ·Ibrahim H. Eissa,Hazem Elkady,Walid E. Elgammal,Hazem A. Mahdy,Eslam B. Elkaeed,Aisha A. Alsfouk,Ibrahim M. Ibrahim,Dalal Z. Husein,Ahmed M. Metwaly	13
5	Unveiling the potential of isatin-grafted phenyl-1,2,3-triazole derivatives as dual VEGFR-2/STAT-3 inhibitors: Design, synthesis and biological assessments 2024 ·Bioorganic Chemistry ·(unknown),Maha‐Hamadien Abdulla,Zainab M. Elsayed,Moataz A. Shaldam,Haytham O. Tawfik,(unknown),(unknown),Thamer Bin Traiki,Eslam B. Elkaeed,Hatem A. Abdel‐Aziz,Wagdy M. Eldehna	16
6	Design, synthesis, in vitro, and in silico studies of new thiadiazol derivatives as promising VEGFR-2 inhibitors and apoptosis inducers 2024 ·Journal of Molecular Structure ·Hazem A. Mahdy,Hazem Elkady,Walid E. Elgammal,Eslam B. Elkaeed,Aisha A. Alsfouk,(unknown),Dalal Z. Husein,Mohamed A. Elkady,Ahmed M. Metwaly,Ibrahim H. Eissa	15
7	New thiazolidine-2,4-diones as effective anti-proliferative and anti-VEGFR-2 agents: Design, synthesis, in vitro, docking, MD simulations, DFT, ADMET, and toxicity studies 2023 ·Computational Biology and Chemistry ·Hazem Elkady,(unknown),(unknown),Mohammed S. Taghour,Mohammed A. Dahab,Hazem A. Mahdy,Alaa Elwan,Hanan Al-Ghulikah,Eslam B. Elkaeed,Ibrahim M. Ibrahim,Dalal Z. Husein,Ahmed M. Metwaly,Ibrahim H. Eissa	16
8	2,4-Diaryl-pyrimido[1,2-a]benzimidazole derivatives as novel anticancer agents endowed with potent anti-leukemia activity: Synthesis, biological evaluation and kinase profiling 2023 ·European Journal of Medicinal Chemistry ·Moataz A. Shaldam,(unknown),Radwan El‐Haggar,(unknown),Taghreed A. Majrashi,Eslam B. Elkaeed,Nicolas Masurier,Vladimı́r Kryštof,Haytham O. Tawfik,Wagdy M. Eldehna	19
9	Escherichia coli-assisted synthesis of AgFeO2 nanoparticles for antimicrobial, photocatalytic and hydrogen generation applications 2023 ·Materials Chemistry and Physics ·Tanzeela Fazal,Shahid Iqbal,(unknown),Azam Hayat,Mazloom Shah,Sajid Mahmood,(unknown),Ahmad Alhujaily,Bibi Nazia Murtaza,(unknown),Randa A. Althobiti,Eman Alzahrani,Abd‐ElAziem Farouk,Foziah F. Al-Fawzan,Eslam B. Elkaeed	3
10	Morphologic design of nanogold carriers for a carbonic anhydrase inhibitor: Effect on ocular retention and intraocular pressure 2023 ·International Journal of Pharmaceutics ·Noura G. Eissa,Wagdy M. Eldehna,(unknown),(unknown),(unknown),(unknown),Mahmoud A. El Hassab,Eslam B. Elkaeed,Zainab M. Elsayed,(unknown),(unknown),(unknown),(unknown),Elbadawy A. Kamoun,Claudiu T. Supuran,Mahmoud Elsabahy,Ayat Allam	4
11	Transition metal doped CeO2 for photocatalytic removal of 2-chlorophenol in the exposure of indoor white light and antifungal activity 2023 ·Frontiers in Chemistry ·Muhammad Tahir ul Qamar,Shahid Iqbal,M. Aslam,Ahmad Alhujaily,(unknown),Komal Rızwan,(unknown),Tahir Ali Sheikh,Ali Bahadur,Nasser S. Awwad,Hala A. Ibrahium,Rasmiah S. Almufarij,Eslam B. Elkaeed	13
12	Design, synthesis, anti-proliferative evaluation, docking, and MD simulation studies of new thieno[2,3-d]pyrimidines targeting VEGFR-2 2023 ·RSC Advances ·Souad A. El‐Metwally,Hazem Elkady,Mohamed Hagras,Dalal Z. Husein,Ibrahim M. Ibrahim,Mohammed S. Taghour,Hesham A. El‐Mahdy,Ahmed Ismail,Bshra A. Alsfouk,Eslam B. Elkaeed,Ahmed M. Metwaly,Ibrahim H. Eissa	15
13	A Theobromine Derivative with Anticancer Properties Targeting VEGFR‐2: Semisynthesis, in silico and in vitro Studies 2023 ·ChemistryOpen ·Ibrahim H. Eissa,Reda G. Yousef,Hazem Elkady,Eslam B. Elkaeed,Aisha A. Alsfouk,Dalal Z. Husein,Ibrahim M. Ibrahim,Mohamed M. Radwan,Ahmed M. Metwaly	11
14	Validation of a Cost-Effective RP-HPLC Method for Quantitative Investigation of Daclatasvir Dihydrochloride in Pharmaceutical Formulations 2023 ·Journal of Chemistry ·(unknown),Muhammad Saeed,Mohsin Javed,Nadia Hussain,Shahid Iqbal,(unknown),(unknown),(unknown),Randa A. Althobiti,Eman Alzahrani,Abd‐ElAziem Farouk,(unknown),Eslam B. Elkaeed	2
15	Insight into structural topology and supramolecular assembly of tetrahydrocarbazole-carbonitrile: On the importance of noncovalent interactions and urease inhibitory profile 2023 ·Journal of Molecular Structure ·Sumera Zaib,Aliya Ibrar,Imtiaz Khan,(unknown),Rosa M. Gomila,C. John McAdam,Abdulaziz A. Al–Askar,Eslam B. Elkaeed,Antonio Frontera	8
16	Chiral resolution of (±)-flurbiprofen using molecularly imprinted hydrazidine-modified cellulose microparticles 2023 ·International Journal of Biological Macromolecules ·Huda Salem AlSalem,M. Monier,May Abdullah Abomuti,Rua B. Alnoman,(unknown),(unknown),Soha T. Al‐Goul,Eslam B. Elkaeed,(unknown),(unknown)	10
17	Biological Effect of Quercetin in Repairing Brain Damage and Cerebral Changes in Rats: Molecular Docking and In Vivo Studies 2022 ·BioMed Research International ·Ahmed B. M. Mehany,Amany Belal,Eman Y. Santali,(unknown),Mohammed A. S. Abourehab,(unknown),(unknown),(unknown),Eslam B. Elkaeed,Ghada Abdelhamid	15
18	New quinoline and isatin derivatives as apoptotic VEGFR-2 inhibitors: design, synthesis, anti-proliferative activity, docking, ADMET, toxicity, and MD simulation studies 2022 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Eslam B. Elkaeed,Mohammed S. Taghour,Hazem A. Mahdy,Wagdy M. Eldehna,Nehal M. El‐Deeb,Ahmed M. Kenawy,Bshra A. Alsfouk,Mohammed A. Dahab,Ahmed M. Metwaly,Ibrahim H. Eissa,Mohamed Ayman El‐Zahabi	58
19	Fabrication of a Ternary Nanocomposite g-C3N4/Cu@CdS with Superior Charge Separation for Removal of Organic Pollutants and Bacterial Disinfection from Wastewater under Sunlight Illumination 2022 ·Toxics ·(unknown),Sammia Shahid,(unknown),Mohsin Javed,Shahid Iqbal,Othman Hakami,(unknown),Foziah F. Al-Fawzan,Eslam B. Elkaeed,Rami Adel Pashameah,Eman Alzahrani,Abd‐ElAziem Farouk	14
20	Isolation, Crystal Structure, and In Silico Aromatase Inhibition Activity of Ergosta-5, 22-dien-3β-ol from the Fungus Gyromitra esculenta 2021 ·Journal of Chemistry ·E. M. Suleimen,Ahmed M. Metwaly,Ahmad E. Mostafa,Eslam B. Elkaeed,Hongwei Liu,Buddha Bahadur Basnet,(unknown),(unknown),К. М. Турдыбеков,(unknown)	19

About Eslam B. Elkaeed

Eslam B. Elkaeed is a scholar working on Toxicology, Organic Chemistry and Computational Theory and Mathematics, having authored 254 papers that have together received 5.3k indexed citations. Recurring topics across this work include Synthesis and biological activity (80 papers), Computational Drug Discovery Methods (44 papers) and Bioactive Compounds and Antitumor Agents (31 papers). The work is most often cited by research in Toxicology (560 citations), Organic Chemistry (2.7k citations) and Computational Theory and Mathematics (887 citations). Eslam B. Elkaeed has collaborated with scholars based in Saudi Arabia, Egypt and Pakistan. Frequent co-authors include Ibrahim H. Eissa, Ahmed M. Metwaly, Hazem Elkady, Wagdy M. Eldehna, Aisha A. Alsfouk, Ibrahim M. Ibrahim, Ahmed A. Al‐Karmalawy, Bshra A. Alsfouk, Mohammed S. Taghour and Dalal Z. Husein. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact